Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
20,220,121
-
Shares change
-
+3,334,386
-
Total reported value, excl. options
-
$164,019,561
-
Value change
-
+$27,081,551
-
Put/Call ratio
-
1.4%
-
Number of buys
-
23
-
Number of sells
-
-34
-
Price
-
$8.1
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q1 2017
86 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q1 2017.
NovoCure Ltd - Common Stock (NVCR) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,220,121 shares
of 111,111,111 outstanding shares and own 18.2% of the company stock.
Largest 10 shareholders include FMR LLC (4,578,561 shares), BlackRock Inc. (3,425,517 shares), VANGUARD GROUP INC (3,047,940 shares), StepStone Group LP (1,815,479 shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1,795,710 shares), PEREGRINE CAPITAL MANAGEMENT LLC (1,210,934 shares), STATE STREET CORP (924,947 shares), NORTHERN TRUST CORP (509,651 shares), COURAGE CAPITAL MANAGEMENT LLC (476,717 shares), and Rock Springs Capital Management LP (214,316 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.